FUKOKU MUTUAL LIFE INSURANCE Co Continues to Hold Position in Stryker Corporation (SYK)

FUKOKU MUTUAL LIFE INSURANCE Co maintained its stake in shares of Stryker Corporation (NYSE:SYK) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 900 shares of the medical technology company’s stock at the end of the 2nd quarter. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Stryker Corporation were worth $125,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in Stryker Corporation by 2.8% during the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after purchasing an additional 657,656 shares during the last quarter. BlackRock Inc. lifted its position in Stryker Corporation by 5.2% during the second quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock valued at $3,208,017,000 after purchasing an additional 1,139,082 shares during the last quarter. Wellington Management Group LLP lifted its position in Stryker Corporation by 0.5% during the first quarter. Wellington Management Group LLP now owns 4,569,118 shares of the medical technology company’s stock valued at $601,525,000 after purchasing an additional 24,139 shares during the last quarter. Geode Capital Management LLC lifted its position in Stryker Corporation by 6.3% during the first quarter. Geode Capital Management LLC now owns 2,786,406 shares of the medical technology company’s stock valued at $366,255,000 after purchasing an additional 166,133 shares during the last quarter. Finally, Jensen Investment Management Inc. lifted its position in Stryker Corporation by 9.9% during the second quarter. Jensen Investment Management Inc. now owns 2,220,791 shares of the medical technology company’s stock valued at $308,201,000 after purchasing an additional 200,192 shares during the last quarter. Institutional investors and hedge funds own 74.10% of the company’s stock.

In related news, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the sale, the insider now directly owns 8,983 shares in the company, valued at $1,313,853.58. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The disclosure for this sale can be found here. 7.40% of the stock is owned by company insiders.

Stryker Corporation (NYSE SYK) opened at 149.32 on Friday. The company has a 50 day moving average of $143.99 and a 200 day moving average of $140.95. Stryker Corporation has a 52 week low of $106.48 and a 52 week high of $150.00. The stock has a market capitalization of $55.86 billion, a P/E ratio of 33.33 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.02. The company had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. Stryker Corporation’s revenue was up 6.1% on a year-over-year basis. During the same period last year, the company earned $1.39 earnings per share. Equities analysts expect that Stryker Corporation will post $6.45 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be given a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a yield of 1.14%. Stryker Corporation’s dividend payout ratio is presently 37.95%.

Several equities research analysts have issued reports on the stock. Cowen and Company set a $160.00 target price on shares of Stryker Corporation and gave the company a “buy” rating in a research report on Friday, October 6th. Zacks Investment Research lowered shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. BidaskClub upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Royal Bank Of Canada lifted their target price on shares of Stryker Corporation from $140.00 to $155.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $148.00 target price on shares of Stryker Corporation and gave the company a “hold” rating in a research report on Friday, July 28th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $146.78.

ILLEGAL ACTIVITY WARNING: This piece was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/10/20/fukoku-mutual-life-insurance-co-continues-to-hold-position-in-stryker-corporation-syk.html.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply